Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SQOR | Q9Y6N5 | 1/20 | 0.32 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.31 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
| ▸ | APP | P05067 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | CASP1 | P29466 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5567642 | 1.00 | SQOR (0.32) | SQORCYP1A1CYP1A2CYP2D6CYP1B1 | |
| SCHEMBL5562545 | 0.90 | MAPT (0.36) | SQORAPPMAPTCASP1 | |
| SCHEMBL1750961 | 0.89 | NR1H2 (0.40) | — | |
| SCHEMBL1750963 | 0.89 | NR1H2 (0.40) | — | |
| SCHEMBL5561371 | 0.82 | ROCK1 (0.33) | SQORCYP3A4MAPTCASP1 | |
| SCHEMBL5562265 | 0.82 | SQOR (0.36) | SQORCYP3A4MAPTCASP1 | |
| SCHEMBL1750386 | 0.78 | NR1H2 (0.40) | MAPT | |
| SCHEMBL5567692 | 0.77 | PARP1 (0.36) | — | |
| SCHEMBL5567828 | 0.77 | KDM4E (0.40) | CYP2D6CYP3A4 | |
| SCHEMBL5562320 | 0.76 | CYP1A2 (0.37) | CYP1A2CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1751141-A1 | NOVEL PYRIDAZINONE DERIVATIVES AS INHIBITORS OF CDK2 | Aventis Pharma S.A. (FR) | 2007-02-14 | — | — | EP | disclosed |
| WO-2005111019-A1 | NOVEL PYRIDAZINONE DERIVATIVES AS INHIBITORS OF CDK2 | AVENTIS PHARMA S.A. (FR) | 2005-11-24 | — | — | WO | disclosed |